Hyperekplexia-associated mutations in the neuronal glycine transporter 2.

Affiliation

Centro de Biología Molecular ''Severo Ochoa'', Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Spain; IdiPAZ-Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: [Email]

Abstract

Hyperekplexia or startle disease is a dysfunction of inhibitory glycinergic neurotransmission characterized by an exaggerated startle in response to trivial tactile or acoustic stimuli. Although rare, this disorder can have serious consequences, including sudden infant death. One of the most frequent causes of hyperekplexia are mutations in the SLC6A5 gene, encoding the neuronal glycine transporter 2 (GlyT2), a key component of inhibitory glycinergic presynapses involved in synaptic glycine recycling though sodium and chloride-dependent co-transport. Most GlyT2 mutations detected so far are recessive, but two dominant missense mutations have been described. The detailed analysis of these mutations has revealed structural cues on the quaternary structure of GlyT2, and opens the possibility that novel selective pharmacochaperones have potential therapeutic effects in hyperekplexia.

Keywords

Dominant mutation,GlyT2,Glycine transporter,Hyperekplexia,Intracellular trafficking,Structure,

OUR Recent Articles